-
Founded in:
2000-11-13 -
Country:
China -
Address:
No. 3809 Huangshan Avenue, Bengbu City -
Tax NO.:
91340300723348633W -
Registered Funds:
98.5 million yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| GLUCOSE |
Glucose is one of the main sources of calories for the human body
More
Glucose is one of the main sources of calories for the human body |
5g/1100ml, 10g/2100ml, 12.5g/250ml, 25g/250ml, 25g/500ml, 50g/500mlg/ml | 58367-01-4 | 15 |
| Sodium chloride |
Sodium and chloride are important electrolytes in the body, mainly present in extracellular fluid, and play a very important role in maintaining the normal volume and osmotic pressure of blood and extracellular fluid in the human body.
More
Sodium and chloride are important electrolytes in the body, mainly present in extracellular fluid, and play a very important role in maintaining the normal volume and osmotic pressure of blood and extracellular fluid in the human body. |
0.9g/1100ml, 0.9g/2100ml, 2.25g/250ml, 2.25g/250ml, 4.5g/500ml, 4.5g/500mlg/ml | 7647-14-5 | 43 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Bromhexine hydrochloride |
This product acts directly on the bronchial glands, can release the lysosomes of mucus secreting cells, thereby depolymerizing the mucopolysaccharides in the mucus and reducing the viscosity of the mucus; it can also cause the respiratory tract to secrete low-viscosity small-molecule mucins, making the sputum thinner and easier to cough up.
More
This product acts directly on the bronchial glands, can release the lysosomes of mucus secreting cells, thereby depolymerizing the mucopolysaccharides in the mucus and reducing the viscosity of the mucus; it can also cause the respiratory tract to secrete low-viscosity small-molecule mucins, making the sputum thinner and easier to cough up. |
8mg | 611-75-6 | 26 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Irbesartan |
Irbesartan is a potent, orally active, selective angiotensin-II receptor (AT1 subtype) antagonist that blocks all AT1 receptor-mediated angiotensin-II effects. Its selective antagonism of angiotensin-II receptors (AT1) leads to increased plasma renin and angiotensin-II levels and decreased plasma aldosterone levels. Irbesartan does not inhibit angiotensin-converting enzyme (ACE kininase II), which generates angiotensin-II, and can also degrade bradykinin into inactive metabolites. Irbesartan's activity does not require metabolic activation, and there is no evidence of abnormal body or target organ toxicity when used at clinically relevant doses.
More
Irbesartan is a potent, orally active, selective angiotensin-II receptor (AT1 subtype) antagonist that blocks all AT1 receptor-mediated angiotensin-II effects. Its selective antagonism of angiotensin-II receptors (AT1) leads to increased plasma renin and angiotensin-II levels and decreased plasma aldosterone levels. Irbesartan does not inhibit angiotensin-converting enzyme (ACE kininase II), which generates angiotensin-II, and can also degrade bradykinin into inactive metabolites. Irbesartan's activity does not require metabolic activation, and there is no evidence of abnormal body or target organ toxicity when used at clinically relevant doses. |
138402-11-6 | 65 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Irbesartan |
This product is an angiotensin II (Ang II) receptor inhibitor, which can inhibit the conversion of Ang I to Ang II, and can specifically antagonize angiotensin converting enzyme 1 receptor (AT1). Its antagonism to AT1 is greater than AT28500 times. It selectively blocks the binding of Ang II to AT1 receptor, inhibits vasoconstriction and the release of aldosterone, and produces a hypotensive effect. This product does not inhibit angiotensin converting enzyme (ACE), renin, other hormone receptors, nor does it inhibit ion channels related to blood pressure regulation and sodium balance.
More
This product is an angiotensin II (Ang II) receptor inhibitor, which can inhibit the conversion of Ang I to Ang II, and can specifically antagonize angiotensin converting enzyme 1 receptor (AT1). Its antagonism to AT1 is greater than AT28500 times. It selectively blocks the binding of Ang II to AT1 receptor, inhibits vasoconstriction and the release of aldosterone, and produces a hypotensive effect. This product does not inhibit angiotensin converting enzyme (ACE), renin, other hormone receptors, nor does it inhibit ion channels related to blood pressure regulation and sodium balance. |
138402-11-6 | 65 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Procaterol hydrochloride |
This product is a β2 receptor agonist with a high selectivity for the β2 adrenergic receptors of bronchial smooth muscle, thereby relaxing the bronchial smooth muscle; it also has a certain anti-allergic effect and promotes respiratory cilia movement.
More
This product is a β2 receptor agonist with a high selectivity for the β2 adrenergic receptors of bronchial smooth muscle, thereby relaxing the bronchial smooth muscle; it also has a certain anti-allergic effect and promotes respiratory cilia movement. |
81262-93-3 | 6 |